The Role of the Matrix Metalloproteinase Stromelysin in the Progression of Squamous Cell Carcinomas
Open Access
- 1 September 1991
- journal article
- ssid mini-symposium
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 302 (3) , 157-162
- https://doi.org/10.1097/00000441-199109000-00008
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.Molecular and Cellular Biology, 1990
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990
- Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.Proceedings of the National Academy of Sciences, 1989
- Growth Factors Regulate Transin Gene Expression by c- fos -Dependent and c- fos -Independent PathwaysScience, 1988
- Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotypeBiochemical and Biophysical Research Communications, 1988
- The collagenase gene family in humans consists of at least four membersBiochemical Journal, 1988
- Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progressionMolecular Carcinogenesis, 1988
- The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.Proceedings of the National Academy of Sciences, 1986
- Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.Molecular and Cellular Biology, 1986